ClinicalTrials.gg
Status unknownNCT04087616Updated Sep 12, 2019

Internet-based CBIT for Children With Chronic Tics

An interventional study of ICBIT and waiting list in Tourette Syndrome in Children, Tourette Syndrome in Adolescence and Chronic Tic Disorder, sponsored by Tel Aviv Medical Center. Status unknown at 2 sites in Israel. Open to participants aged 8 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-09-12.

Primary conditionTourette SyndromeRegistry: Tic DisordersReclassifiedWhy we changed it
Registry
Tic Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Tourette Syndrome
Why
  1. The study's listed conditions name Tourette Syndrome, a narrower term within Tic Disorders.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Tel Aviv Medical Center · Not applicable, Interventional, and Treatment

How we know

The sponsor has not verified this record recently (last verified Sep 2019), so the status shown — last known as Recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
8 Years to 17 Years
Sex
All
01

Study summary

To evaluate the effect and acceptability of an Internet-based comprehensive behavioral intervention for tics (ICBIT) in a sample of children and adolescents with Tic disorders. children and adolescents (aged 8-17 years) with Tourette Syndrome (TS) or Chronic Tic Disorder (CTD) and their parents will be randomly assigned to receive either an Internet-based ICBIT or wait-list (WL).

Read the detailed description

To evaluate the effect and acceptability of an Internet-based comprehensive behavioral intervention for tics (ICBIT) in a sample of children and adolescents with Tic disorders, children and adolescents (aged 8-17 years) with Tourette Syndrome (TS) or Chronic Tic Disorder (CTD) and their parents will be randomly assigned to receive either an Internet-based ICBIT or wait-list (WL) condition in a cross over design.

Participants will be randomized to ICBIT, or to wait list, and half will cross over from wait list to ICBT. Two blind independent clinical evaluators will rate tic severity and comorbidity. The primary outcome measure is the Yale Global Tic Severity Scale (YGTSS). Assessments will be performed at baseline, post-ICBT or post wait list, 3-months and 6-months (post-treatment for those originally assigned to ICBT) and post-ICBT, 3-months and 6-months (post-treatment for those originally assigned to wait list condition). All assessments were conducted by 2 PhD level independent child psychologists.

02

Conditions studied

  • Tourette Syndrome in Children
  • Tourette Syndrome in Adolescence
  • Chronic Tic Disorder

Browse trials for

Keywords

  • tics
  • tourette Syndrome
03

In context

Tourette Syndrome Reclassified

240 studies on the registry are indexed under Tourette Syndrome; 40 are open to participants now.

This study's planned enrollment of 40 is above the median of 36 across 183 interventional studies indexed under Tourette Syndrome.

Browse Tourette Syndrome studies →

Lead sponsor

Tel Aviv Medical Center is the lead sponsor of 10 studies on the registry; 2 are open to participants now.

Compared within Tourette Syndrome, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Tic Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
8 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Clinical diagnosis of Tourette Syndrome or Chronic Tic Disorder.
  • Yale Global Tic Severity Scale tic severity score ≥14.

Exclusion criteria

Exclusion Criteria:

  • Change in psychotropic medication regimen during the past 6 weeks.
  • Current diagnosis of substance abuse/dependence.
  • Lifetime diagnosis of pervasive developmental disorder, mania or psychosis.
  • Previous sessions of CBIT.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    CBIT

    ICBIT. Intervention delivered through an internet platform called Managing children's' tics (www.cbteamathome.co.il), based on CBIT protocol (Woods et al., 2008) adapted to an online parent-guided self-help format.

    Behavioral: ICBIT

  • Placebo comparator
    Waiting List

    Participants initially assigned to the wait list receive no psychosocial intervention for 9 weeks. Following post-WL assessment, all participants receive ICBIT.

    Behavioral: waiting list

Interventions

  • BehavioralICBIT

    The intervention consists of 9 modules delivered over 9 weeks comprise of age-appropriate texts and descriptive diagrams, animations, films of clinicians demonstrating techniques such as competing response exercising.

  • Behavioralwaiting list

    Participants initially assigned to the wait list received no psychosocial intervention for 9 weeks. Following post-WL assessment, all participants chose to receive ICBIT.

06

What researchers measure

Primary outcomes

  1. Yale Global Tic Severity Scale (YGTSS)

    Time frame: change from baseline YGTSS total score at 3 months

07

Study locations

2 of 2 sites recruiting
08

References and documents

Publications

  • Rachamim L, Zimmerman-Brenner S, Rachamim O, Mualem H, Zingboim N, Rotstein M. Internet-based guided self-help comprehensive behavioral intervention for tics (ICBIT) for youth with tic disorders: a feasibility and effectiveness study with 6 month-follow-up. Eur Child Adolesc Psychiatry. 2022 Feb;31(2):275-287. doi: 10.1007/s00787-020-01686-2. Epub 2020 Nov 24. PubMed 33231786 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2019 (actual). Primary completion is estimated for Jan 2020, 6 months after the start.

Of 65 non-industry interventional studies with no phase under Tourette Syndrome, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 50. This study's planned 6 months is below that.

Counting every sponsor, half of 65 studies reached it within 33 months; a quarter within 22 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 24, 2019
First posted
Sep 12, 2019
StartActual
Jul 1, 2019
Primary completionEst.
Jan 31, 2020
CompletionEst.
May 1, 2020
Last update
Sep 12, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 12, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04087616
Lead sponsor
Tel Aviv Medical Center
Responsible party
Michael Rotstein (Head, Pediatric Movement Disorder Clinic, Principal Investigator, Tel-Aviv Sourasky Medical Center) — Principal investigator
First posted
Sep 12, 2019
Start date
Jul 1, 2019
Primary completion
Jan 31, 2020 (estimated)
Completion
May 1, 2020 (estimated)
Last update
Sep 12, 2019

Study contacts

Lilch Rachamim
Contact
lilach.rachamim7@gmail.com
+972528374405
Michael Rotstein, MD
Contact
michaelr@tlvmc.gov.il
+972524266760

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion